SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-24-000073
Filing Date
2024-10-16
Accepted
2024-10-16 16:13:42
Documents
13
Period of Report
2024-10-10
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K jazz-20241010.htm   iXBRL 8-K 26221
  Complete submission text file 0001232524-24-000073.txt   156376

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20241010.xsd EX-101.SCH 1910
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20241010_lab.xml EX-101.LAB 23507
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20241010_pre.xml EX-101.PRE 13530
16 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20241010_htm.xml XML 2906
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 241374762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)